Equity Research

Matt Phipps Reacts to Medicare Drug Pricing Announcement in Barron’s

William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.

Our Latest News

Wednesday, March 26, 2025

StoneX Group Inc.: Initiation of Research Coverage

William Blair initiated research coverage of StoneX Group Inc., a global financial services network that connects clients to global markets through digital platforms, end-to-end clearing and execution services, and risk management solutions.
Read more
Tuesday, March 25, 2025

Immunic, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Immunic, Inc. (IMUX $1.13), a clinical-stage biotech developing novel therapies for chronic inflammatory and autoimmune disorders.
Read more
Monday, March 24, 2025

Navigating the Boom: Confronting GenAI’s Most Pressing Questions

Delve into William Blair’s latest generative AI report, “Navigating the Boom: Confronting GenAI’s Most Pressing Questions.” Featuring insights from technology analysts Jason Ader, Arjun Bhatia, and Sebastien Naji, this episode explores the current state of AI, industry trends, and the future of AI development.
Listen to the podcast

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures

William Blair Thinking

William Blair Thinking Podcast

William Blair Thinking

Matt Phipps Reacts to Medicare Drug Pricing Announcement in Barron’s

Our Latest News

StoneX Group Inc.: Initiation of Research Coverage

Immunic, Inc.: Initiation of Research Coverage

Navigating the Boom: Confronting GenAI’s Most Pressing Questions

Are you sure you want to leave?